A common chemotherapy drug could carry a toxic inheritance for children and grandchildren of adolescent cancer survivors, Washington State University-led research indicates.
Nov 28, 2022
0
708
The U.S. Food and Drug Administration approved the combination of tremelimumab (Imjudo) plus durvalumab (Imfinzi) and platinum-based chemotherapy for adult patients with metastatic non-small cell lung cancer with no sensitizing ...
Nov 16, 2022
0
47
Cardiovascular disease is the leading cause of mortality in breast cancer survivors. A new study out of the Baker Heart and Diabetes Institute has found that exercise training three to four times per week protects against ...
Nov 8, 2022
0
21
A new treatment developed at Tel Aviv University may significantly enhance the efficacy of chemotherapy in breast cancer patients, reducing the risk for lung metastasis following chemo from 52% to only 6%. Conducted in an ...
Nov 7, 2022
0
73
MicroRNA (miRNA) can be used as a biomarker to predict which patients are likely to face breast cancer recurrence and mortality, according to study results published online ahead of print in the Journal of the American College ...
Nov 4, 2022
0
21
A small team of medical researchers from the U.K. and the U.S. has found that a cancer patient may have put her cancer into remission by taking cannabis oil and magic mushrooms along with receiving a standard course of chemotherapy. ...
The Supreme Court of the United States (SCOTUS) ruling in Dobbs vs. Jackson overruled Roe vs. Wade, returning an individual's right to access abortion services to state law. Now, new findings led by researchers at the American ...
Sep 26, 2022
0
58
Researchers in China have discovered that inhibiting a protein called the GABAA receptor can protect intestinal stem cells from the toxic effects of chemotherapy and radiotherapy.
Sep 20, 2022
0
4
Among patients with early-stage triple-negative breast cancer (TNBC), the pathologic complete response (pCR) rate for durvalumab added to neoadjuvant chemotherapy is 46 percent, with similar rates for African American (AA) ...
Aug 19, 2022
0
5
The U.S. Food and Drug Administration has approved Enhertu (am-trastuzumab-deruxtecan-nxki), an intravenous infusion treatment for patients with unresectable or metastatic human epidermal growth factor receptor 2 (HER2)-low ...
Aug 9, 2022
0
20
